1 Clinical success (eg 50% reduction in pain) |
10 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
1.1 Acute conditions |
4 |
324 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.93 [1.51, 2.46] |
1.2 Chronic conditions |
6 |
455 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.58 [1.22, 2.04] |
2 Adverse events |
11 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
2.1 Any adverse event |
11 |
984 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.56 [1.19, 2.04] |
2.2 Local adverse events |
10 |
869 |
Risk Ratio (M‐H, Fixed, 95% CI) |
2.15 [1.12, 4.12] |
3 Withdrawals |
7 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
3.1 Lack of efficacy |
5 |
501 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.36 [0.15, 0.87] |
3.2 Adverse events |
7 |
737 |
Risk Ratio (M‐H, Fixed, 95% CI) |
4.19 [1.52, 11.56] |